• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.23% Nasdaq Up1.74%

    IsoRay, Inc. (ISR)

    1.39 Up 0.02(1.46%) Oct 2, 4:02PM EDT
    ProfileGet Profile for:
    IsoRay, Inc.
    350 Hills Street
    Suite 106
    Richland, WA 99354
    United States - Map
    Phone: 509-375-1202
    Website: http://www.isoray.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:35

    Business Summary 

    IsoRay, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces Proxcelan Cesium-131 brachytherapy seeds for the treatment of prostate, lung, head and neck, colorectal, brain, pelvic/abdominal, and gynecological cancers, as well as ocular melanoma. It also offers GliaSite radiation therapy system, a balloon catheter device, which is used to treat brain cancer, including primary and recurrent gliomas and metastic brain tumors. The company is headquartered in Richland, Washington.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on IsoRay, Inc.

    Key Executives 
    Mr. Dwight Babcock , 67
    Chairman and Chief Exec. Officer
    Mr. Brien L. Ragle , 46
    Chief Financial Officer
    Mr. William Cavanagh III, 49
    VP of R&D
    Krista Cline ,
    Corp. Sec.
    Dr. Steven M. Kurtzman M.D., 53
    Medical Advisor of IsoRay Medical Inc
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders